Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT06510465
Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA) (NeoURANIA)
Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA): A Multi-center, Prospective Study
Sponsor: RenJi Hospital
Conditions
Breast Cancer
Interventions
Cisplatin Pertuzumab Trastuzumab utidelone
Updated 2 times since 2024 Last updated: Jul 14, 2024 Started: Aug 1, 2024 Primary completion: Mar 31, 2027 Completion: Mar 31, 2032
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE2 trial investigates Breast Cancer and is currently actively recruiting participants. RenJi Hospital leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
2 versions recorded-
Sep 2024 — Present [monthly]
Not Yet Recruiting PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- RenJi Hospital
Data source: RenJi Hospital
For direct contact, visit the study record on ClinicalTrials.gov .